PAUL J HASTINGS

CIK 1309702 · Chief Executive Officer · last filed 2026-01-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.41M

Companies

6

Total Filings

77

Lifetime Open-Market Net

-$3.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NKTX Chief Executive Officer 390,023 $2.86 $1.12M -$1.59M 21 2026-01-20
ENGNW Director $0.27 $0 2 2025-06-16
PCRX Director 12,724 $22.99 $292.5K -$2.27M 30 2024-06-13
PRTO Director $27.65 $0 3 2018-06-11
Relypsa Inc (RLYP) Delisted Director 0 -$69.9K 5 2016-09-02
VIACELL INC (VIAC) Delisted Director $29.58 $0 1 2007-06-01

Recent Filings · Page 4 of 8

77 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-01-12 NKTX Grant (A) $0 EDGAR
2020-07-13 NKTX Grant (A) $0 EDGAR
2020-06-11 PCRX Grant (A) +1,260 $0 EDGAR
2020-06-08 PCRX Sell (S) −2,025 -$96.1K EDGAR
2019-06-06 PCRX Mixed +3,352 -$33.4K EDGAR
2018-06-15 PCRX Grant (A) +782 $0 EDGAR
2018-06-11 PRTO Grant (A) $0 EDGAR
2018-06-06 PCRX Sell (S) −771 -$26.1K EDGAR
2017-10-12 Sell (S) −1,398 -$5.9K
2017-08-24 PCRX Sell (S) −1,044 -$37.7K EDGAR
Showing 3140 of 77
Page 4 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.